The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

2018 ◽  
Vol 55 (4) ◽  
pp. 341-353 ◽  
Author(s):  
ShadiSadat Seyyedebrahimi ◽  
Hadi Khodabandehloo ◽  
Ensieh Nasli Esfahani ◽  
Reza Meshkani
Keyword(s):  
Oxidative Stress ◽  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Markers Of Oxidative Stress

Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

2021 ◽  
pp. 1-10
Author(s):  
Joana Furtado de Figueiredo Neta ◽  
Vivian Saraiva Veras ◽  
Danilo Ferreira de Sousa ◽  
Maria da Conceição dos Santos Oliveira Cunha ◽  
Maria Veraci Oliveira Queiroz ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Metabolic Control ◽  
Curcuma Longa ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo

Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial

2017 ◽  
Vol 31 (10) ◽  
pp. 1539-1545 ◽  
Author(s):  
Fatemeh Homayouni ◽  
Fatemeh Haidari ◽  
Mehdi Hedayati ◽  
Mehrnoosh Zakerkish ◽  
Kambiz Ahmadi
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Lipid Peroxidation ◽  
Dna Damage ◽  
Oxidative Dna Damage ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo

21-OR: Final Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the MetAP2 Inhibitor ZGN-1061 in Patients with Type 2 Diabetes

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 21-OR ◽  
Author(s):  
TERRI KIM ◽  
DONGLIANG ZHUANG ◽  
TONYA L. HAUGEN ◽  
DENNIS D. KIM ◽  
KRISTIN TAYLOR
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document